» Articles » PMID: 34221974

GEFT Inhibits Autophagy and Apoptosis in Rhabdomyosarcoma Activation of the Rac1/Cdc42-mTOR Signaling Pathway

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Jul 5
PMID 34221974
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Autophagy and apoptosis are dynamic processes that determine the fate of cells, and regulating these processes can treat cancer. GEFT is highly expressed in rhabdomyosarcoma (RMS), which accelerates the tumorigenicity and metastasis of RMS by activating Rac1/Cdc42 signaling, but the regulatory mechanisms of autophagy and apoptosis are unclear. In our study, we found that the RMS tissues had high Rac1, Cdc42, mTOR, and Bcl-2 expression levels and low Beclin1, LC3, and Bax expression levels compared with the normal striated muscle tissues ( < 0.05). In addition, multivariate analysis has proven that Rac1 is an independent prognostic factor ( < 0.05), and the high expression level of the Beclin1 protein was closely associated with the tumor diameter of the RMS patients ( = 0.044), whereas the high expression level of the LC3 protein was associated with the clinical stage of the RMS patients ( = 0.027). Furthermore, GEFT overexpression could inhibit autophagy and apoptosis in RMS. A Rac1/Cdc42 inhibitor was added, and the inhibition of autophagy and apoptosis decreased. Rac1 and Cdc42 could regulate mTOR to inhibit autophagy and apoptosis in RMS. Overall, these studies demonstrated that the GEFT-Rac1/Cdc42-mTOR pathway can inhibit autophagy and apoptosis in RMS and provide evidence for innovative treatments.

Citing Articles

GEFT inhibits the GSDM-mediated proptosis signalling pathway, promoting the progression and drug resistance of rhabdomyosarcoma.

Yang F, Xia T, Zhao Z, Lin J, Zhong L, Tang T Cell Death Dis. 2024; 15(11):867.

PMID: 39616223 PMC: 11608370. DOI: 10.1038/s41419-024-07243-y.


The cellular adaptor GULP1 interacts with ATG14 to potentiate autophagy and APP processing.

Chau D, Yu Z, Chan W, Yuqi Z, Chang R, Ngo J Cell Mol Life Sci. 2024; 81(1):323.

PMID: 39080084 PMC: 11335243. DOI: 10.1007/s00018-024-05351-8.


Molecular basis and current insights of atypical Rho small GTPase in cancer.

Huang H, Wang S, Guan Y, Ren J, Liu X Mol Biol Rep. 2024; 51(1):141.

PMID: 38236467 DOI: 10.1007/s11033-023-09140-7.


Radioresistance in rhabdomyosarcomas: Much more than a question of dose.

Camero S, Cassandri M, Pomella S, Milazzo L, Vulcano F, Porrazzo A Front Oncol. 2022; 12:1016894.

PMID: 36248991 PMC: 9559533. DOI: 10.3389/fonc.2022.1016894.


TRIM65 Promotes Cervical Cancer Through Selectively Degrading p53-Mediated Inhibition of Autophagy and Apoptosis.

Wang X, Mao H, Guan X, Huang Q, Yu Z, Wu J Front Oncol. 2022; 12:853935.

PMID: 35402260 PMC: 8987532. DOI: 10.3389/fonc.2022.853935.


References
1.
Lu J, Zang H, Zheng H, Zhan Y, Yang Y, Zhang Y . Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer. PLoS One. 2020; 15(2):e0227768. PMC: 7001968. DOI: 10.1371/journal.pone.0227768. View

2.
Deshmukh J, Pofahl R, Haase I . Epidermal Rac1 regulates the DNA damage response and protects from UV-light-induced keratinocyte apoptosis and skin carcinogenesis. Cell Death Dis. 2017; 8(3):e2664. PMC: 5386559. DOI: 10.1038/cddis.2017.63. View

3.
Friedrichs K, Gluba S, Eidtmann H, Jonat W . Overexpression of p53 and prognosis in breast cancer. Cancer. 1993; 72(12):3641-7. DOI: 10.1002/1097-0142(19931215)72:12<3641::aid-cncr2820721215>3.0.co;2-8. View

4.
Li X, Su J, Xia M, Li H, Xu Y, Ma C . Caspase-mediated cleavage of Beclin1 inhibits autophagy and promotes apoptosis induced by S1 in human ovarian cancer SKOV3 cells. Apoptosis. 2015; 21(2):225-38. DOI: 10.1007/s10495-015-1197-y. View

5.
Su Z, Yang Z, Xu Y, Chen Y, Yu Q . Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer. 2015; 14:48. PMC: 4343053. DOI: 10.1186/s12943-015-0321-5. View